CurrentEndo
Get Weekly

Topic · page 29 of 119

Type 2 & other diabetes

Type 2 diabetes and prediabetes: prevention, remission, glucose-lowering drugs, weight-based treatment, insulin, lifestyle and diet; monogenic and other specific types of diabetes

Briefs 1,121–1,160 of 4,758 placed here, newest publication first

Briefs in Type 2 & other diabetes

Newest publication first

  1. Diabetes Obes Metab

    The association between glycaemic control, normal weight and long‐term macrovascular outcomes in people with type 2 diabetes in China: A retrospective study

    Cohort study

  2. Diabetes Obes Metab

    Anabolic androgenic steroid use and risk of diabetes mellitus in males

    Cohort study

  3. Diabetes Res Clin Pract

    Altitude and type 2 diabetes mellitus: an inverse ecological association across two representative Andean populations

    Research article

  4. Diabet Med

    Trends in admissions for hyperglycaemic emergencies and associated clinical factors in adults with type 2 diabetes in Singapore, 2013–2022

    Case-control study

  5. Diabetes Metab

    Handgrip strength cut-off points for identifying French adults at risk of type 2 diabetes

    Cohort study

  6. BMJ Open Diabetes Res Care

    Performance of an individualized, subcutaneous, basal-bolus insulin regimen for the management of prednisolone-associated hyperglycemia in hospitalized patients: a proof-of-concept study

    Cross-sectional study

  7. Diabetes Res Clin Pract

    Meta-analysis on the validity and clinical utility of the IDF/DAR risk stratification tool

    Meta-analysis

  8. Diabetes Res Clin Pract

    A machine learning model for hypoglycemia risk prediction in hospitalized patients with diabetes: development and validation

    Cohort study

  9. Diabetologia

    Cardiovascular effectiveness and safety of SGLT2 inhibitors vs DPP4 inhibitors by dementia status: a cohort study of older adults with diabetes

    Cohort study

  10. Diabetes Care

    Association of Age at Type 2 Diabetes Onset With Diabetes Progression

    Secondary analysis

  11. Cardiovasc Diabetol

    Neurodegeneration onset with glucagon-like peptide-1 receptor agonists in people with type 2 diabetes: a real-world multinational cohort study

    Cohort study

  12. Cardiovasc Diabetol

    Sex differences in the prognostic value of urinary albumin-to-creatinine ratio for coronary artery disease and cardiovascular events in people with type 2 diabetes and normoalbuminuria

    Cohort study

  13. Lancet Diabetes Endocrinol

    Time trends in mortality from heart failure and atherosclerotic cardiovascular disease in people with and without diabetes: a multi-national population-based study

    Cohort study

  14. Diabetes Care

    Changes in Type 2 Diabetes Medications Among Primary Care Patients After California’s 2022 Medicaid Expansion

    Cohort study

  15. Cardiovasc Diabetol

    Increased high-risk plaque burden in type 2 diabetes: a 10-year follow-up study

    Cohort study

  16. Diabetes Obes Metab

    Efficacy and safety of switching to ezetimibe 10 mg/rosuvastatin 2.5 mg in Korean patients with type 2 diabetes mellitus and dyslipidaemia: A multicentre, prospective study ( EROICA study)

    Cohort study

  17. J Clin Endocrinol Metab

    HMGCR and Rosuvastatin Regulates GLP-1 Secretion and Expression—A Translational Study

    Mechanistic study

  18. Cardiovasc Diabetol

    Empagliflozin-induced lipidome remodeling in type 2 diabetes: mechanistic insights and translational perspectives

    Secondary analysis

  19. Diabetes Res Clin Pract

    A 12-month mHealth low-carbohydrate dietary intervention improved clinical and psychosocial outcomes in people with type 2 diabetes

    Research article

  20. BMJ Open Diabetes Res Care

    Associations between perceived stress and glycemic measures: gender and age as moderators

    Cross-sectional study

  21. BMJ Open Diabetes Res Care

    Combination therapy with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists in heart failure patients with type 2 diabetes

    Cohort study

  22. Ann Intern Med

    Comparative Gastrointestinal Safety of Dulaglutide, Semaglutide, and Tirzepatide in Adults With Type 2 Diabetes

    Cohort study

  23. BMJ Open Diabetes Res Care

    Metabolic factors moderate the association between hepatic fibrosis and atherosclerotic cardiovascular risk in type 2 diabetes

    Cross-sectional study

  24. Diabetes Obes Metab

    One‐year usage patterns of SGLT ‐2 inhibitors and GLP ‐1 receptor agonists in individuals with type 2 diabetes in a real‐world population

    Cohort study

  25. BMJ Open Diabetes Res Care

    Sex-specific protective role of lower-body fat in type 2 diabetes: mediation through insulin resistance in a BMI-matched population

    Cross-sectional study

  26. Diabetes Obes Metab

    Cardiorespiratory fitness and type 2 diabetes risk: A prospective cohort study with mediation analysis of biological aging in the UK Biobank

    Cohort study

  27. Cardiovasc Diabetol

    HFpEF as the predominant and underrecognized heart failure phenotype in type 2 diabetes: evidence from the DIABET-IC study

    Secondary analysis

  28. Diabetes Obes Metab

    Pharmacological intervention: Challenges and promising outcomes for fat loss and preservation of lean body mass in the treatment of overweight and type 2 diabetes

    Research article

  29. Diabetes Obes Metab

    Synergistic associations of metformin and GLP ‐1 receptor agonist use with adiposity‐related cancer incidence in people living with type 2 diabetes

    Cohort study

  30. Diabetes Obes Metab

    Progressive increases in adiposity and ectopic fat surrogates across glycaemic states highlight weight reduction as a key target for type 2 diabetes prevention, especially in younger people

    Cross-sectional study

  31. Diabetes Obes Metab

    Importance of targeting post‐prandial hyperglycaemia to achieve HbA1c goals in insulin glargine‐treated subphenotypes of type 2 diabetes

    Meta-analysis

  32. Diabetes Obes Metab

    Availability and readiness of health facilities for chronic kidney disease, diabetes and cardiovascular disease in Ethiopia: Evidence from service provision assessment data

    Cross-sectional study

  33. JAMA Netw Open

    Cost-Effectiveness of MASH Diagnosis and Management Approaches Among Those With Type 2 Diabetes

    Cohort study

  34. Diabetes Res Clin Pract

    Cumulative burdens as determinants of diabetes self-management: examining disparities across income levels

    Cross-sectional study

  35. JAMA Netw Open

    Early Life Exposure to the Great Chinese Famine and Cardiometabolic Outcomes

    Cohort study

  36. JAMA Netw Open

    Population-Level Health Intervention and Primary Care Quality for Veterans

    Cohort study

  37. Diabetes Obes Metab

    Evolving trends of antidiabetic agents stratified by age, kidney function and body mass index: Insights from a nationwide claims database

    Cohort study

  38. Diabetes Obes Metab

    Two‐tier screening approach for liver fibrosis stratification in outpatients with type 2 diabetes mellitus: A multicenter cross‐sectional study

    Cross-sectional study

  39. J Diabetes Sci Technol

    Use of an Electronic Health Record–Embedded Glycemic Management Protocol to Improve Perioperative Glucose Control in People With Diabetes

    Cohort study

  40. Diabetes Res Clin Pract

    Risk of lower extremity complications with GLP-1 receptor agonists, SGLT2 inhibitors, and DPP-4 inhibitors in peripheral artery disease

    Cohort study

All 4,758 Briefs in ExploreShowing Briefs 1,121–1,160 of 4,758, newest first